PD-L1 expressing CTC were detected in 94.5% of BC patients.Patients with non-metastatic BC had significantly more PD-L1-positive CTC than patients without metastasis (median 75% versus 61.1%; p <0.05). This evidence concerns the gene CD274 and breast cancer.